Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02966860 · ClinicalTrials.gov registry record · Phase 1
Single-Dose PK Study of an Oxycodone/Acetaminophen Solution in Healthy Subjects
A Phase 1 study, sponsored by Mallinckrodt.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT02966860 is a Phase 1 study that has completed, run by Mallinckrodt. The registered enrollment target is 18 participants.
The verdict
NCT02966860, a Phase 1 study, has completed, sponsored by Mallinckrodt.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
A single-dose study evaluating the oral PK of an oxycodone/apap solution in healthy subjects under fasted conditions
Interventions
- DRUG Oral solution OC/APAP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2016-08 |
| Est. Completion | 2016-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02966860
The ClinicalTrials.gov registry entry for NCT02966860 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mallinckrodt, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oral solution OC/APAP is the first listed.
NCT02966860 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02966860 about?
NCT02966860 is a clinical study titled "Single-Dose PK Study of an Oxycodone/Acetaminophen Solution in Healthy Subjects". A single-dose study evaluating the oral PK of an oxycodone/apap solution in healthy subjects under fasted conditions
What is the current status of trial NCT02966860?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2016-08. Estimated completion is 2016-11.
What interventions are being tested in trial NCT02966860?
The interventions under investigation include: Oral solution OC/APAP (DRUG).
Who is sponsoring clinical trial NCT02966860?
This trial is sponsored by Mallinckrodt, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.